Your browser doesn't support javascript.
loading
Anti-Rituximab antibody in patients with NMOSDs treated with low dose Rituximab.
Li, Ting; Zhang, Lin-Jie; Zhang, Qiu-Xia; Yang, Chun-Sheng; Zhang, Chao; Li, Yu-Jing; Shi, Fu-Dong; Yang, Li.
Afiliación
  • Li T; Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, 154 Anshan Road, Heping District, Tianjin 300052, China.
  • Zhang LJ; Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, 154 Anshan Road, Heping District, Tianjin 300052, China.
  • Zhang QX; Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, 154 Anshan Road, Heping District, Tianjin 300052, China.
  • Yang CS; Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, 154 Anshan Road, Heping District, Tianjin 300052, China.
  • Zhang C; Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, 154 Anshan Road, Heping District, Tianjin 300052, China.
  • Li YJ; Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, 154 Anshan Road, Heping District, Tianjin 300052, China.
  • Shi FD; Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, 154 Anshan Road, Heping District, Tianjin 300052, China; Department of Neurology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ 85013, USA.
  • Yang L; Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, 154 Anshan Road, Heping District, Tianjin 300052, China. Electronic address: yangli2001@tmu.edu.cn.
J Neuroimmunol ; 316: 107-111, 2018 03 15.
Article en En | MEDLINE | ID: mdl-29310942

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neuromielitis Óptica / Rituximab / Factores Inmunológicos / Anticuerpos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Neuroimmunol Año: 2018 Tipo del documento: Article País de afiliación: China Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neuromielitis Óptica / Rituximab / Factores Inmunológicos / Anticuerpos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Neuroimmunol Año: 2018 Tipo del documento: Article País de afiliación: China Pais de publicación: Países Bajos